Literature DB >> 8799537

Does the cerebrospinal fluid protein concentration increase the risk of shunt complications?

H L Brydon1, R Hayward, W Harkness, R Bayston.   

Abstract

A prospective study was performed to determine whether the popular opinion that a high CSF protein concentration increases the risk of shunt complications is true. Ninety-five patients were enrolled into the study and they had 116 shunt operations over 15 months. It was considered that the CSF protein content might influence the development of complications that occurred within 2 months of surgery. Shunt complications occurred following 24.6% of operations within this period. This included 12 infections, 13 obstructions and three cases of overdrainage. The distribution of complications, compared to CSF protein content, was non-significant on a chi 2-test (p > 0.5). The total protein content of each of the complication groups was also analysed using the Mann-Whitney U-test and the differences were non-significant for the infection (0.1 > p > 0.05) and obstruction groups (0.5 > p > 0.1). It is concluded that an elevated CSF protein content does not increase the risk of shunt complications, and that there is no reason why shunting should be delayed in patients with a high CSF protein content.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799537     DOI: 10.1080/02688699650040124

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  11 in total

1.  Hydrocephalus--what's new?

Authors:  P Chumas; A Tyagi; J Livingston
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

2.  Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption.

Authors:  H L Brydon; G Keir; E J Thompson; R Bayston; R Hayward; W Harkness
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  Subduro-peritoneal shunts in the management of subdural collection related to ruptured intracranial arachnoid cysts.

Authors:  Marco Ceraudo; Alessandro Prior
Journal:  Childs Nerv Syst       Date:  2020-11-03       Impact factor: 1.475

Review 4.  Shunts vs endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review.

Authors:  C Di Rocco; L Massimi; G Tamburrini
Journal:  Childs Nerv Syst       Date:  2006-10-20       Impact factor: 1.475

5.  Use of intrathecal urokinase in repeated shunt and external ventricular drain blockage from high CSF protein due to an optic pathway glioma.

Authors:  David Shooman; Girish V Vajramani; Jennifer Davidson; Owen C Sparrow
Journal:  Childs Nerv Syst       Date:  2009-12-16       Impact factor: 1.475

6.  Evaluation of Ventriculoperitoneal Shunt-Related Complications in Intracranial Meningioma with Hydrocephalus.

Authors:  Shyamal C Bir; Shabal Sapkota; Tanmoy K Maiti; Subhas Konar; Papireddy Bollam; Anil Nanda
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-02

Review 7.  Brain metastases as a cause of malignant cerebrospinal fluid ascites: case report and review of the literature.

Authors:  Yin Yee Sharon Low; John Thomas; Wei Keat Wan; Wai Hoe Ng
Journal:  CNS Oncol       Date:  2012-09

8.  Cerebrospinal fluid alterations following endoscopic third ventriculostomy with choroid plexus cauterization: a retrospective laboratory analysis of two tertiary care centers.

Authors:  Michael C Dewan; Jonathan Dallas; Shilin Zhao; Burkely P Smith; Stephen Gannon; Fakhry Dawoud; Heidi Chen; Chevis N Shannon; Brandon G Rocque; Robert P Naftel
Journal:  Childs Nerv Syst       Date:  2019-11-28       Impact factor: 1.475

9.  Nuclear Medicine to Evaluate Complications of Cerebral Shunts: Two Cases and Review of Literature.

Authors:  Beth Vettiyil; Sabrina Bessette; Samuel McQuiston; Francis Greiner
Journal:  World J Nucl Med       Date:  2015 Sep-Dec

Review 10.  Cerebrospinal fluid circulation: What do we know and how do we know it?

Authors:  Ahmad H Khasawneh; Richard J Garling; Carolyn A Harris
Journal:  Brain Circ       Date:  2018-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.